Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly

Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong

NCT02957890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Nudge and Motivational Interviewing Interventions to Improve Influenza Vaccine Uptake Among Healthcare Workers in China

NCT07157163 ·Status: NOT_YET_RECRUITING ·Phase: NA

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

NCT01967368 ·Status: UNKNOWN ·Phase: PHASE4

Effectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care Setting

NCT04568785 ·Status: COMPLETED ·Phase: NA

Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong

NCT03330132 ·Status: COMPLETED ·Phase: PHASE4

Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children

NCT00792051 ·Status: COMPLETED ·Phase: NA

Childhood Influenza Immunisation in General Practice Invitation Trial

NCT02921633 ·Status: COMPLETED ·Phase: NA

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

NCT00342940 ·Status: WITHDRAWN ·Phase: PHASE2

Direct and Indirect Benefits of Influenza Vaccination in Schools and Households

NCT00981513 ·Status: COMPLETED ·Phase: PHASE4

Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge

NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

From Innovation to Solutions: Childhood Influenza Vaccination Planning

NCT01664793 ·Status: COMPLETED ·Phase: NA

Pilot Text Message for Influenza Vaccination

NCT01761734 ·Status: COMPLETED ·Phase: NA

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

NCT00329927 ·Status: COMPLETED ·Phase: PHASE2

Factors Associated With Maintenance of Antibody Responses to Influenza Vaccine in Older, Community-Dwelling Adults

NCT02401893 ·Status: COMPLETED

Mood and Influenza Vaccine Response: A Feasibility Trial

NCT03144518 ·Status: COMPLETED ·Phase: NA

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects

NCT00522236 ·Status: COMPLETED ·Phase: PHASE2

Improving Influenza Vaccination Rates Among Health Care Professionals

NCT00404664 ·Status: COMPLETED ·Phase: NA

Increasing the Uptake of Influenza and Pneumococcal Vaccines Among High-Risk Adult Patients Through GP Clinics

NCT03445117 ·Status: COMPLETED ·Phase: NA

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects

NCT00518726 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older

NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1

Childhood Influenza Immunisation Invitation Trial in Schools

NCT02883972 ·Status: WITHDRAWN ·Phase: NA

Heterosubtypic Immune Responses to Influenza in Older People

NCT00798343 ·Status: COMPLETED ·Phase: PHASE1

Effects of Age on Response to the 2009 H1N1 Virus Vaccine

NCT01055184 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine

NCT01265914 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

NCT05313893 ·Status: COMPLETED ·Phase: PHASE4